Finance

Beta
Lists
CTHRQ:OTCMKTS
Charles & Colvard Ltd
$0.0011
0.00%
(0.00) 1D
Jun 2, 2:40:56 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTHRQ...
Mkt. cap
4.92K
Avg. vol.
772.00
Volume
3.00
52-wk high
$0.14
52-wk low
$0.00
Beta
1.39
Shares outstanding
4.47M
No. of employees
24
Mkt. cap
4.92K
Avg. vol.
772.00
Volume
3.00
52-wk high
$0.14
52-wk low
$0.00
Beta
1.39
Shares outstanding
4.47M
No. of employees
24
News stories
From sources across the web
Profile
Charles & Colvard, Ltd., is a publicly traded American company that distributes and manufactures jewelry, founded in 1995 by Charles Eric Hunter under the name C3 Inc., and then run by his brother Jeff Hunter until 2000. The company changed its name to Charles & Colvard in 1999. The company employs 63 people full-time, and generated $32.4 million in revenue during the year ending June 30, 2019, up from $27.91 million in the previous year. Charles & Covard was the first company to produce and sell synthetic moissanite, under U.S. patent US5723391 A, first filed by C3 Inc., North Carolina. Their gemstones are made from silicon carbide crystals, supplied under an exclusive agreement from Cree Inc. since 2014. In June 2019 the company netted $10 million from a secondary public offering. In March 2020, the company was notified that they were at risk of being delisted on NASDAQ, as their share price had been consistently below $1. Don O'Connell was announced CEO in May 2020, taking over after Suzanne T. Miglucci's resignation. The announcement came days after reporting their quarterly earnings, which included a $5.3 million writeoff. Wikipedia
About Charles & Colvard Ltd
CEODon O'Connell
Employees24
Founded1995
HeadquartersMorrisville, North Carolina, United States
SectorLuxury goods
Websitecharlesandcolvard.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Revenue
3.84M
3.23M
4.63M
4.05M
Cost of goods sold
3.31M
2.23M
3.12M
3.12M
Cost of revenue
3.31M
2.23M
3.12M
3.12M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.07M
3.14M
4.04M
2.90M
Operating expense
3.07M
3.14M
4.04M
2.90M
Total operating expenses
6.38M
5.37M
7.17M
6.02M
Operating income
-2.54M
-2.14M
-2.54M
-1.97M
Other non operating income
-
-
-
-
EBT including unusual items
-5.32M
-2.13M
-2.54M
-1.97M
EBT excluding unusual items
-2.53M
-2.13M
-2.54M
-1.97M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.32M
-2.13M
-2.54M
-1.97M
Net profit margin
-138.82%
-65.98%
-54.79%
-48.73%
Earnings per share
-
-
-
-
Interest and investment income
56.57K
43.64K
38.11K
16.14K
Interest expense
-43.05K
-38.54K
-35.62K
-21.10K
Net interest expenses
13.53K
5.10K
2.49K
-4.96K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.37M
-1.92M
-2.32M
-1.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer